- Trials with a EudraCT protocol (1,179)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (18,700)
1,179 result(s) found.
Displaying page 1 of 59.
EudraCT Number: 2004-000955-40 | Sponsor Protocol Number: CI-1008-152 | Start Date*: 2004-09-23 |
Sponsor Name:Pfizer Global Research & Development | ||
Full Title: A Placebo-Controlled Study of Pregabalin in Elderly Patients With Generalized Anxiety Disorder | ||
Medical condition: Generalized Anxiety Disorder | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: LV (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-002961-35 | Sponsor Protocol Number: ILP.021.250/01L | Start Date*: 2005-09-19 |
Sponsor Name:AS "GRINDEKS" | ||
Full Title: MILDRONĀTA PIELIETOŠANAS EFEKTIVITĀTE UN DROŠĪBA SLIMNIEKIEM AR MIJKLIBOŠANU (CLAUDICATIO INTERMITTENS) | ||
Medical condition: PERIFĒRO ARTĒRIJU SLIMĪBA (PAS) AR MIJKLIBOŠANU (CLAUDICATIO INTERMITTENS) (II STADIJA PĒC FONTAINE) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: LV (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-002902-74 | Sponsor Protocol Number: EML 017008-004 | Start Date*: 2006-07-21 |
Sponsor Name:Merck Santé s.a.s. | ||
Full Title: A double-blind, double-dummy, randomized, controlled, multi-centre study of the activity and safety of 2 daily doses of EMD 387008 versus placebo and metformin in parallel groups after 8 weeks of t... | ||
Medical condition: Phase II study on type 2 diabetic subjects | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: LV (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-003087-70 | Sponsor Protocol Number: PM1125 | Start Date*: 2011-12-02 |
Sponsor Name:Polichem SA | ||
Full Title: Randomized, open-label, controlled study on the efficacy of Ciclopoli® (ciclopirox 8% nail lacquer) versus Loceryl® (amorolfine 5% nail lacquer) on the culture conversion to negative in patients w... | ||
Medical condition: distal subungual onychomycosis without lunula involvement due to fungal nail pathogens (dermatophytes, white yeasts and/or Scopulariopsis spp. and/or Fusarium spp.) affecting at least one big toenail | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: LV (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-003776-10 | Sponsor Protocol Number: N3D/FOR-OCA-08 | Start Date*: 2004-10-22 |
Sponsor Name:Neuro3d | ||
Full Title: Safety amd tolerability of ocaperidone in the continuation treatment of patients with schizophrenia: a double-blind, parallel group, multicentre, fixed dose, follow-up study | ||
Medical condition: The population of the study will be: - schizophrenic patients according to DSM IV-TR diagnosis - have to present the first symptoms of the schizophrenia for at least one year - have to present an e... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: LV (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-003399-36 | Sponsor Protocol Number: MK-4214-008 | Start Date*: 2011-10-28 | |||||||||||||||||||||
Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. | |||||||||||||||||||||||
Full Title: A Phase III Randomized, Double-Blind, Active-Controlled Clinical Trial to Study the Efficacy and Safety of MK-4214 (filgrastim) and Neupogen™ as an Adjunct to Combination Chemotherapy with Doxorubi... | |||||||||||||||||||||||
Medical condition: Breast Cancer | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||||||||||||
Trial protocol: LV (Prematurely Ended) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2004-001154-86 | Sponsor Protocol Number: 20020149 | Start Date*: 2004-09-06 | |||||||||||
Sponsor Name:Amgen Inc. | |||||||||||||
Full Title: A Multicenter, Double-blind, Placebo-controlled Roll-over Study to Protocol 20010103 of Darbepoetin Alfa for the Treatment of Anemia of Cancer | |||||||||||||
Medical condition: Anemia of cancer in subjects who are not receiving chemotherapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LV (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-018004-18 | Sponsor Protocol Number: 205.418 | Start Date*: 2010-09-20 | |||||||||||
Sponsor Name:Boehringer Ingelheim RCV GmbH&Co KG | |||||||||||||
Full Title: A Phase III randomised, double-blind, placebo-controlled, parallel-group trial to evaluate efficacy and safety of tiotropium inhalation solution delivered via Respimat® inhaler (2.5 and 5 μg once d... | |||||||||||||
Medical condition: Moderate persistent asthma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LV (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-001187-52 | Sponsor Protocol Number: AX.- CL – 06a | Start Date*: 2004-11-12 | |||||||||||
Sponsor Name:Axonyx Corporation | |||||||||||||
Full Title: A Randomised, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Two Different Dosages of Phenserine-tartrate in Patients with Mild to Moderate Probable Alzheimer’s Disea... | |||||||||||||
Medical condition: Alzheimer’s Disease is a chronic progressive illness leading to loss of cognitive and intellectual abilities such as memory function, judgement and abstract thinking. In addition to the cognitive d... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LV (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001487-23 | Sponsor Protocol Number: TPU-SL-EU05-02 | Start Date*: 2006-06-05 |
Sponsor Name:Teikoku Pharma USA, Inc. | ||
Full Title: A Double Blind Randomized Controlled Study of the Effiacy and Safety of Topical Sterile 5% Lidocaine Patch in the Treatment of Postoperative Pain Due to Plastic Surgery of the Breast | ||
Medical condition: Postoperative Pain Due to the Plastic Surgery of the Breast | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: LV (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2011-002456-14 | Sponsor Protocol Number: OAS-11PAC-W-fu | Start Date*: 2011-10-21 | |||||||||||
Sponsor Name:Oasmia Pharmaceutical AB | |||||||||||||
Full Title: A follow-up study exploring number of cycles for weekly treatment with Paclical® in patients with metastatic breast cancer, previously treated in study OAS-11PAC-W | |||||||||||||
Medical condition: Histologically confirmed metastatic breast cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: LV (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-012444-16 | Sponsor Protocol Number: 39758979ASH2001 | Start Date*: 2009-09-25 | |||||||||||
Sponsor Name:Janssen-Cilag International NV | |||||||||||||
Full Title: A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Exploratory Study of the Safety and Efficacy of JNJ-39758979 in the Treatment of Adults with Persistent Asthma | |||||||||||||
Medical condition: JNJ-39756979 is being developed for the treatment of asthma. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: LV (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-004462-40 | Sponsor Protocol Number: TMC207-TiDP13-C208 | Start Date*: 2007-12-20 | |||||||||||
Sponsor Name:Tibotec BVBA | |||||||||||||
Full Title: A Phase II, placebo-controlled, double-blind, randomized trial to evaluate the anti-bacterial activity, safety, and tolerability of TMC207 in subjects with sputum smear-positive pulmonary infection... | |||||||||||||
Medical condition: Tuberculosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: LV (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003816-19 | Sponsor Protocol Number: V4061 | Start Date*: 2016-10-14 |
Sponsor Name:ForSight VISION4, Inc | ||
Full Title: A Controlled Safety and Preliminary Efficacy Study of the V406 Port Delivery System in the Treatment of Choroidal Neovascularization Due toAge-Related Macular Degeneration | ||
Medical condition: Patients of either sex, 50 years of age or older, with a diagnosis of Choroidal Neovascularization CNV due to Age-Related Macular Degeneration AMD in the study eye | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: LV (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2015-002417-29 | Sponsor Protocol Number: NN2211-4232 | Start Date*: 2016-01-08 | |||||||||||
Sponsor Name:Novo Nordisk A/S | |||||||||||||
Full Title: Efficacy in controlling glycaemia with Victoza® (liraglutide) as add-on to metformin vs. OADs as add-on to metformin after up to 104 weeks of treatment in subjects with type 2 diabetes inadequately... | |||||||||||||
Medical condition: Diabetes Mellitus, Type 2 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LV (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-005161-12 | Sponsor Protocol Number: OAS-12DOC-BIO | Start Date*: 2015-10-22 | |||||||||||||||||||||||||||||||
Sponsor Name:Oasmia Pharmaceutical AB | |||||||||||||||||||||||||||||||||
Full Title: A multi-country, multicenter, randomized, open-label, parallel group study to assess the efficacy and safety of Docecal compared with Taxotere® | |||||||||||||||||||||||||||||||||
Medical condition: adenocarcinoma of the breast | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||||||||||||||||||||||
Trial protocol: LV (Prematurely Ended) | |||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-002481-31 | Sponsor Protocol Number: IM011-011 | Start Date*: 2017-02-02 | |||||||||||
Sponsor Name:Bristol-Myers Squibb International Corporation | |||||||||||||
Full Title: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Phase 2 Study to Evaluate the Clinical Efficacy and Safety of BMS-986165 in Subjects with Moderate to Severe Psoriasis | |||||||||||||
Medical condition: Moderate to Severe Psoriasis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LV (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-001041-15 | Sponsor Protocol Number: N3D/FOR-OCA-06 | Start Date*: 2004-07-26 |
Sponsor Name:Neuro3d | ||
Full Title: MULTICENTRE, DOUBLE-BLIND, RISING DOSE PARALLEL GROUP STUDY OF THE EFFICACY AND TOLERABILITY OF OCAPERIDONE VERSUS OLANZAPINE IN SCHIZOPHRENIC PATIENTS | ||
Medical condition: The populations of the study will be: -schizophrenic patients according to DSM IV-TR diagnosis -have to present the first symptoms of the schizophrenia for at least one year -have to present an exa... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: LV (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2004-000954-22 | Sponsor Protocol Number: CI-1008-100 | Start Date*: 2004-09-23 |
Sponsor Name:Pfizer Global Research & Development | ||
Full Title: A 1-Year Open-Label Safety Extension Study of Pregabalin (CI-1008) in Patients With Anxiety Disorders | ||
Medical condition: Generalized Anxiety Disorder | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: LV (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-005179-32 | Sponsor Protocol Number: GRMSS-04-07 | Start Date*: 2008-09-15 |
Sponsor Name:Joint Stock Company "Grindeks" | ||
Full Title: Mildronate - Efficacy And Safety Of Treatment For Chronic Coronary Heart Disease (Stable Angina) I | ||
Medical condition: Chronic coronary heart disease (stable angina) | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: LV (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.